Fox Run Management L.L.C. Buys New Stake in American Healthcare REIT, Inc. $AHR

Fox Run Management L.L.C. bought a new stake in American Healthcare REIT, Inc. (NYSE:AHRFree Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 17,446 shares of the company’s stock, valued at approximately $821,000.

Several other large investors have also recently added to or reduced their stakes in the business. Erste Asset Management GmbH increased its position in American Healthcare REIT by 14.2% in the 4th quarter. Erste Asset Management GmbH now owns 29,000 shares of the company’s stock valued at $1,401,000 after acquiring an additional 3,600 shares during the period. JPMorgan Chase & Co. increased its position in American Healthcare REIT by 23.6% in the 4th quarter. JPMorgan Chase & Co. now owns 579,481 shares of the company’s stock valued at $27,270,000 after acquiring an additional 110,765 shares during the period. Los Angeles Capital Management LLC acquired a new stake in American Healthcare REIT in the 4th quarter valued at approximately $34,000. 111 Capital acquired a new stake in American Healthcare REIT in the 4th quarter valued at approximately $205,000. Finally, WINTON GROUP Ltd acquired a new stake in American Healthcare REIT in the 4th quarter valued at approximately $1,655,000. 16.68% of the stock is currently owned by institutional investors and hedge funds.

American Healthcare REIT Stock Performance

AHR opened at $46.81 on Thursday. The company has a quick ratio of 0.45, a current ratio of 0.45 and a debt-to-equity ratio of 0.28. The firm has a market cap of $9.02 billion, a PE ratio of 80.71, a P/E/G ratio of 1.57 and a beta of 0.80. The business has a fifty day simple moving average of $49.21 and a 200-day simple moving average of $49.27. American Healthcare REIT, Inc. has a fifty-two week low of $34.86 and a fifty-two week high of $54.67.

American Healthcare REIT (NYSE:AHRGet Free Report) last issued its earnings results on Thursday, May 7th. The company reported $0.13 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.34). The company had revenue of $650.77 million during the quarter, compared to analyst estimates of $667.57 million. American Healthcare REIT had a return on equity of 3.33% and a net margin of 4.23%.The business’s revenue was up 20.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.38 earnings per share. American Healthcare REIT has set its FY 2026 guidance at 2.030-2.090 EPS. As a group, equities analysts predict that American Healthcare REIT, Inc. will post 2.06 EPS for the current fiscal year.

American Healthcare REIT Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, April 17th. Investors of record on Tuesday, March 31st were issued a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date was Tuesday, March 31st. American Healthcare REIT’s payout ratio is presently 172.41%.

Wall Street Analysts Forecast Growth

AHR has been the topic of several analyst reports. Citigroup restated a “market outperform” rating on shares of American Healthcare REIT in a research report on Wednesday. The Goldman Sachs Group set a $60.00 price target on American Healthcare REIT in a research note on Monday, March 2nd. Weiss Ratings lowered American Healthcare REIT from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, June 2nd. Royal Bank Of Canada increased their price target on American Healthcare REIT from $54.00 to $56.00 and gave the company an “outperform” rating in a research note on Tuesday, May 26th. Finally, Scotiabank increased their price target on American Healthcare REIT from $55.00 to $59.00 and gave the company a “sector outperform” rating in a research note on Wednesday, March 11th. One equities research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $55.64.

View Our Latest Analysis on AHR

Insider Activity

In related news, EVP Mark E. Foster sold 2,000 shares of American Healthcare REIT stock in a transaction on Monday, June 1st. The stock was sold at an average price of $48.32, for a total value of $96,640.00. Following the transaction, the executive vice president directly owned 55,495 shares in the company, valued at $2,681,518.40. The trade was a 3.48% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.75% of the stock is owned by insiders.

American Healthcare REIT Company Profile

(Free Report)

American Healthcare REIT, Inc (NYSE: AHR) was a publicly traded real estate investment trust focused on acquiring, owning and managing healthcare‐related properties across the United States. The company’s portfolio spanned senior housing communities, skilled nursing facilities, medical office buildings and outpatient care centers, all operated under long‐term net lease or triple‐net lease structures designed to provide stable, predictable rental income.

Employing a strategy of partnering with established healthcare operators, American Healthcare REIT targeted properties in both major metropolitan areas and high‐growth secondary markets to capitalize on demographic trends such as an aging population and increased demand for outpatient services.

Read More

Want to see what other hedge funds are holding AHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for American Healthcare REIT, Inc. (NYSE:AHRFree Report).

Institutional Ownership by Quarter for American Healthcare REIT (NYSE:AHR)

Receive News & Ratings for American Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.